CytomX Therapeutics (CTMX) Short Interest Ratio & Short Volume $0.54 -0.07 (-10.78%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$0.54 +0.00 (+0.17%) As of 08:24 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CytomX Therapeutics Short Interest DataCytomX Therapeutics (CTMX) has a short interest of 9.00 million shares, representing 12.37% of the float (the number of shares available for trading by the public). This marks a 91.49% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.0, indicating that it would take 5.0 days of the average trading volume of 2.63 million shares to cover all short positions.Current Short Interest9,000,000 sharesPrevious Short Interest4,700,000 sharesChange Vs. Previous Month+91.49%Dollar Volume Sold Short$5.85 millionShort Interest Ratio5.0 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares80,100,000 sharesShort Percent of Float12.37%Today's Trading Volume1,233,461 sharesAverage Trading Volume2,627,596 sharesToday's Volume Vs. Average47% Short Selling CytomX Therapeutics? Sign up to receive the latest short interest report for CytomX Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCTMX Short Interest Over TimeCTMX Days to Cover Over TimeCTMX Percentage of Float Shorted Over Time Remove Ads CytomX Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20259,000,000 shares $5.85 million +91.5%12.4%5 $0.65 2/28/20254,700,000 shares $3.18 million +6.8%6.5%2.6 $0.68 2/15/20254,400,000 shares $3.50 million -3.3%6.0%3.9 $0.80 1/31/20254,550,000 shares $3.87 million -1.7%N/A3.6 $0.85 1/15/20254,630,000 shares $3.97 million -3.5%N/A3.6 $0.86 12/31/20244,800,000 shares $4.94 million -13.4%N/A3.9 $1.03 12/15/20245,540,000 shares $6.15 million +26.2%N/A4.8 $1.11 11/30/20244,390,000 shares $4.65 million -1.1%N/A4 $1.06 11/15/20244,440,000 shares $4.04 million -21.7%N/A5.5 $0.91 10/31/20245,670,000 shares $5.65 million -6.6%N/A7.4 $1.00 Get the Latest News and Ratings for CTMX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/15/20246,070,000 shares $6.80 million -2.9%N/A9.4 $1.12 9/30/20246,250,000 shares $7.38 million -10.5%N/A9.1 $1.18 9/15/20246,980,000 shares $8.59 million -2.4%N/A8.2 $1.23 8/31/20247,150,000 shares $8.44 million -9.2%N/A6.5 $1.18 8/15/20247,870,000 shares $9.37 million +1.7%N/A6 $1.19 7/31/20247,740,000 shares $10.68 million No ChangeN/A2.5 $1.38 7/15/20247,740,000 shares $10.91 million -3.9%N/A1.2 $1.41 6/30/20248,050,000 shares $9.82 million +3.7%N/A1.2 $1.22 6/15/20247,760,000 shares $10.71 million -1.8%N/A1.2 $1.38 5/31/20247,900,000 shares $13.43 million -9.7%N/A1.2 $1.70 5/15/20248,750,000 shares $17.15 million +143.1%N/A1.4 $1.96 4/30/20243,600,000 shares $5.87 million +0.3%N/A0.6 $1.63 4/15/20243,590,000 shares $7.07 million +8.1%N/A4 $1.97 3/31/20243,320,000 shares $7.24 million -6.0%N/A3.8 $2.18 3/15/20243,530,000 shares $7.31 million +115.2%N/A4.1 $2.07 2/29/20241,640,000 shares $4.02 million +26.2%N/A2.2 $2.45 2/15/20241,300,000 shares $1.95 million +4.0%N/A2.8 $1.50 1/31/20241,250,000 shares $1.91 million -5.3%N/A4.2 $1.53 1/15/20241,320,000 shares $2.28 million -0.8%N/A4.4 $1.73 12/31/20231,330,000 shares $2.06 million +35.5%N/A4.9 $1.55 12/15/2023981,600 shares $1.38 million -26.8%N/A5 $1.41 11/30/20231,340,000 shares $1.86 million +0.8%N/A7.5 $1.39 11/15/20231,330,000 shares $1.72 million +5.6%N/A8 $1.29 10/31/20231,260,000 shares $1.39 million -18.2%N/A7 $1.10 10/15/20231,540,000 shares $1.93 million -9.9%N/A8.5 $1.25 9/30/20231,710,000 shares $2.21 million -23.0%N/A9.5 $1.29 9/15/20232,220,000 shares $3.06 million +2.3%N/A8.2 $1.38 8/31/20232,170,000 shares $3.26 million +5.9%N/A7.5 $1.50 8/15/20232,050,000 shares $3.26 million -21.5%N/A6.5 $1.59 7/31/20232,610,000 shares $4.54 million -3.0%4.0%7 $1.74Trump’s Secret Weapon (Ad)Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.Get Your FREE Presidential Transition Guide Today 7/15/20232,690,000 shares $4.90 million +13.0%4.1%6.8 $1.82 6/30/20232,380,000 shares $4.09 million No Change3.7%5.3 $1.72 6/15/20232,380,000 shares $3.71 million +4.4%3.7%4.5 $1.56 5/31/20232,280,000 shares $3.90 million +7.0%3.5%3.4 $1.71 5/15/20232,130,000 shares $3.88 million -13.4%3.3%2.8 $1.82 4/30/20232,460,000 shares $4.01 million +9.3%3.8%2.8 $1.63 4/15/20232,250,000 shares $3.74 million +40.6%3.5%2 $1.66 3/31/20231,600,000 shares $2.42 million -14.9%2.5%1 $1.51 3/15/20231,880,000 shares $3.82 million +48.0%2.9%0.8 $2.03 2/28/20231,270,000 shares $2.73 million -8.0%2.0%0.5 $2.15 2/15/20231,380,000 shares $3.20 million -13.8%2.1%0.5 $2.32 1/31/20231,600,000 shares $4.32 million -43.3%2.5%0.5 $2.70 1/15/20232,820,000 shares $8.07 million +433.7%4.3%1 $2.86 12/30/2022528,400 shares $845,440.00 -64.1%0.8%0.2 $1.60 12/15/20221,470,000 shares $2.34 million -26.1%2.3%1.1 $1.59 11/30/20221,990,000 shares $3.46 million +103.7%3.1%1.6 $1.74 11/15/2022977,100 shares $1.16 million -2.0%1.5%0.8 $1.19 10/31/2022997,400 shares $1.31 million -6.8%1.6%2 $1.31 10/15/20221,070,000 shares $1.52 million -10.8%1.7%1.6 $1.42 9/30/20221,200,000 shares $1.74 million +2.6%1.9%1.3 $1.45 9/15/20221,170,000 shares $1.94 million +30.9%1.9%0.7 $1.66 8/31/2022894,100 shares $1.34 million -14.0%1.4%0.5 $1.50 8/15/20221,040,000 shares $1.80 million -21.2%1.7%0.6 $1.73 7/31/20221,320,000 shares $1.89 million +1.5%2.1%0.7 $1.43 7/15/20221,300,000 shares $1.95 million +10.2%2.1%0.7 $1.50 6/30/20221,180,000 shares $2.16 million -67.7%1.9%0.7 $1.83 6/15/20223,650,000 shares $6.28 million -4.5%5.9%3.2 $1.72 5/31/20223,820,000 shares $6.15 million -5.5%6.1%3.5 $1.61 5/15/20224,040,000 shares $7.11 million +6.3%6.5%3.8 $1.76 4/30/20223,800,000 shares $6.50 million +37.7%6.2%3.9 $1.71 4/15/20222,760,000 shares $6.38 million -29.6%4.5%3.2 $2.31 3/31/20223,920,000 shares $10.47 million +2.6%6.4%4.4 $2.67 3/15/20223,820,000 shares $11.38 million No Change6.3%3.2 $2.98 2/28/20223,820,000 shares $14.63 million -2.1%6.3%3.4 $3.83 2/15/20223,900,000 shares $15.91 million +11.4%6.4%3.2 $4.08 1/31/20223,500,000 shares $16.10 million -5.4%5.6%2.7 $4.60 1/15/20223,700,000 shares $14.62 million +19.4%5.9%2.9 $3.95 12/31/20213,100,000 shares $13.42 million -22.3%5.0%2.6 $4.33 12/15/20213,990,000 shares $26.65 million +9.0%6.4%3.6 $6.68 11/30/20213,660,000 shares $24.19 million -21.8%5.9%5.3 $6.61 11/15/20214,680,000 shares $33.98 million -3.3%7.5%7.6 $7.26 10/29/20214,840,000 shares $28.70 million +7.6%7.7%8.1 $5.93 10/15/20214,500,000 shares $23.13 million -7.4%7.2%8.1 $5.14 9/30/20214,860,000 shares $24.74 million -7.3%7.7%8.1 $5.09 9/15/20215,240,000 shares $26.04 million -11.2%8.3%7.6 $4.97 8/31/20215,900,000 shares $30.21 million -11.7%9.4%8.6 $5.12 8/13/20216,680,000 shares $32.40 million -4.4%10.6%9.2 $4.85 7/30/20216,990,000 shares $37.82 million +5.1%10.9%9.3 $5.41 7/15/20216,650,000 shares $39.10 million +0.2%10.4%7.5 $5.88 6/30/20216,640,000 shares $42.03 million -0.6%10.4%7 $6.33Trump to redistribute trillions of dollars (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 6/15/20216,680,000 shares $47.29 million +0.6%10.5%7.2 $7.08 5/28/20216,640,000 shares $47.54 million -1.3%10.4%6.8 $7.16 5/14/20216,730,000 shares $55.39 million +1.1%N/A6.8 $8.23 4/30/20216,660,000 shares $63.20 million +7.6%N/A6.6 $9.49 4/15/20216,190,000 shares $44.69 million -3.4%N/A6.2 $7.22 3/31/20216,410,000 shares $47.43 million +63.5%N/A6.2 $7.40 3/15/20213,920,000 shares $33.32 million +17.7%N/A3.9 $8.50 2/26/20213,330,000 shares $26.17 million No ChangeN/A3.7 $7.86 2/12/20213,330,000 shares $27.44 million -8.5%N/A3.9 $8.24 1/29/20213,640,000 shares $25.52 million +20.9%N/A4.6 $7.01 1/15/20213,010,000 shares $23.63 million +3.8%N/A4.4 $7.85 12/31/20202,900,000 shares $19.78 million -3.3%6.5%6.2 $6.82 12/15/20203,000,000 shares $23.70 million -8.8%6.7%6.8 $7.90 11/30/20203,290,000 shares $24.41 million -10.1%7.4%7.9 $7.42 11/15/20203,660,000 shares $27.08 million -7.3%8.2%9 $7.40 10/30/20203,950,000 shares $26.74 million +16.2%8.8%9.7 $6.77 10/15/20203,400,000 shares $23.02 million +10.8%7.6%8 $6.77 9/30/20203,070,000 shares $20.42 million -7.0%6.8%7.2 $6.65 9/15/20203,300,000 shares $23.83 million -6.0%7.4%7.3 $7.22 8/31/20203,510,000 shares $25.62 million +5.7%7.8%7.3 $7.30 8/14/20203,320,000 shares $22.78 million +3.1%7.4%6.1 $6.86 7/31/20203,220,000 shares $22.57 million +20.6%7.2%5.1 $7.01 7/15/20202,670,000 shares $22.83 million -15.8%6.0%4 $8.55 6/30/20203,170,000 shares $26.41 million +88.7%7.2%4.7 $8.33 6/15/20201,680,000 shares $13.37 million +40.0%3.8%2.4 $7.96 5/29/20201,200,000 shares $10.63 million +1.7%2.7%1.8 $8.86 5/15/20201,180,000 shares $10.63 million +10.3%2.7%1.8 $9.01 4/30/20201,070,000 shares $11.04 million -14.4%2.4%2 $10.32 4/15/20201,250,000 shares $10.96 million +44.6%2.8%2.6 $8.77 CTMX Short Interest - Frequently Asked Questions What is CytomX Therapeutics' current short interest? Short interest is the volume of CytomX Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 9,000,000 shares of CTMX short. 12.37% of CytomX Therapeutics' shares are currently sold short. Learn More on CytomX Therapeutics' current short interest. What is a good short interest ratio for CytomX Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTMX shares currently have a short interest ratio of 5.0. Learn More on CytomX Therapeutics's short interest ratio. Which institutional investors are shorting CytomX Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of CytomX Therapeutics: Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for CytomX Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.37% of CytomX Therapeutics' floating shares are currently sold short. Is CytomX Therapeutics' short interest increasing or decreasing? CytomX Therapeutics saw a increase in short interest in March. As of March 15th, there was short interest totaling 9,000,000 shares, an increase of 91.5% from the previous total of 4,700,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does CytomX Therapeutics' short interest compare to its competitors? 12.37% of CytomX Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to CytomX Therapeutics: Eledon Pharmaceuticals, Inc. (2.60%), Foghorn Therapeutics Inc. (3.50%), Inhibrx, Inc. (9.60%), Y-mAbs Therapeutics, Inc. (12.89%), Checkpoint Therapeutics, Inc. (14.22%), Tevogen Bio Holdings Inc. (5.47%), AC Immune SA (2.20%), CARGO Therapeutics, Inc. (18.87%), Voyager Therapeutics, Inc. (5.39%), Amarin Co. plc (2.69%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short CytomX Therapeutics stock? Short selling CTMX is an investing strategy that aims to generate trading profit from CytomX Therapeutics as its price is falling. CTMX shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CytomX Therapeutics? A short squeeze for CytomX Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CTMX, which in turn drives the price of the stock up even further. How often is CytomX Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CTMX, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies ELDN Short Interest FHTX Short Interest INBX Short Interest YMAB Short Interest CKPT Short Interest TVGN Short Interest ACIU Short Interest CRGX Short Interest VYGR Short Interest AMRN Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CTMX) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CytomX Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CytomX Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CTMX Stock Free CTMX Stock Alerts